Table 3. Efficiency and efficacy of the aerial oral rabies vaccination (ORV) campaigns in foxes.
ORV campaign | Type | Bait uptake(1) (%) | 95% C.I. | Herd immunity(2) (%) | 95% C.I. |
December 2009–January 2010 | Emergency | 71.1 | 64.6–77.6 | 75.9 | 69.4–81.6 |
May–June 2010 | Emergency | 63.2 | 59.7–66.9 | 69.1 | 65.1–73.0 |
August–September 2010 | Emergency | 82.5 | 79.3–85.6 | 46.2 | 40.8–51.5 |
November–December 2010 | Emergency | 91.8 | 88.3–95.3 | 77.8 | 73.8–81.4 |
April–May 2011 | Ordinary | 67.7 | 61.7–73.6 | 74.6 | 70.7–78.3 |
November–December 2011 | Ordinary | 86.5 | 82.3–90.6 | 46.3 | 42.3–49.3 |
April–May 2012 | Ordinary | 92.7 | 89.5–96.0 | 60.1 | 56.1–64.1 |
November–December 2012 | Ordinary | 87.4 | 83.8–90.4 | 49.5 | 44.5–54.5 |
May 2013 | Preventive | 65.2 | 49.8–78.6 | 32.2 | 19.6–51.4 |
ORV: oral rabies vaccination.
Detection of biomarker in bones.
Percentage of tested animals with antibody titre > 0.5 UI/ml.